Aprea Therapeutics, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Aprea Therapeutics, Inc. (APRE) had Deferred Tax Assets, Goodwill and Intangible Assets of $26.84 thousand as of 2019-12-31, per its 10-K filed 2021-03-16.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2021-03-16
- 2019-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $26.84K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2019-12-31 | $26.84K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |